Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Participation Deadline: 01/30/2027
Apply Now

Description

The purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program length of stay (LOS) and completion rate.